Difference between revisions of "Postradiation prostatic carcinoma"
Jump to navigation
Jump to search
(→IHC) |
|||
| Line 39: | Line 39: | ||
*CK5/6 -ve. | *CK5/6 -ve. | ||
*p63 -ve. | *p63 -ve. | ||
===Images=== | |||
<gallery> | |||
Image: Prostatic carcinoma and radiation changes - IHC -- low mag.jpg | PC and RC - low mag. | |||
Image: Prostatic carcinoma and radiation changes - IHC -- intermed mag.jpg | PC and RC - intermed. mag. | |||
Image: Prostatic carcinoma and radiation changes - IHC -- high mag.jpg | PC and RC - high mag. | |||
</gallery> | |||
==See also== | ==See also== | ||
Revision as of 05:04, 23 July 2015
Postradiation prostatic carcinoma, also prostate carcinoma after radiation therapy, is uncommon but may be challenging to diagnose.[1]
General
- Overcall and undercall are both seen.[1]
- Commonly missed on core biopsies.
- History of radiation.
Microscopic
Features:[1]
- Infiltrative growth (diagnostic).
- Perineural invasion (diagnostic).
- Intraluminal crystalloids.
- Blue mucin secretions.
- Absence of corpora amylacea.
- Coexistent high-grade prostatic intraepithelial neoplasia.
Note:
- Nuclear enlargement and prominent nucleoli are prevalent in radiation changes of the prostate. These features are not useful in this context.[1]
DDx:
- Radiation changes.
- Pleomorphic tumours.
- Postradiation prostatic sarcoma.[2]
- Sarcomatoid prostatic carcinoma - may arise following radiation.
Images
PC and RC - intermed. mag.
PC and RC - intermed. mag.
PC and RC - high mag.
PC and RC - very high mag.
RC - high mag.
RC - very high mag.
IHC
- AMACR +ve.
- CK5/6 -ve.
- p63 -ve.
Images
PC and RC - low mag.
PC and RC - intermed. mag.
PC and RC - high mag.
See also
References
- ↑ 1.0 1.1 1.2 1.3 Cheng, L.; Cheville, JC.; Bostwick, DG. (Oct 1999). "Diagnosis of prostate cancer in needle biopsies after radiation therapy.". Am J Surg Pathol 23 (10): 1173-83. PMID 10524518.
- ↑ Canfield, SE.; Gans, TH.; Unger, P.; Hall, SJ. (Dec 2001). "Postradiation prostatic sarcoma: de novo carcinogenesis or dedifferentiation of prostatic adenocarcinoma?". Tech Urol 7 (4): 294-5. PMID 11763492.